We have studied the labeling kinetics of peripheral nerve sphingolipids in vivo. The kinetic analysis of the labeling profiles observed for the various sphingolipids demonstrated that 90% of cerebrosides, but only 30% of sphingomyelin, were synthesized via a de novo synthesized ceramide intermediate following the injection of 1-4 pmol [3H]palmitate into mouse sciatic nerves. The remaining sphingolipid labeling (30% of the total) was due to direct acylation events, using free fatty acids originating from a pool different from those implicated in the de novo ceramide pathway.Direct acylation events ceased within 1 h following substrate administration, while labeling via the ceramide pathway continued through 5 h. The results provide the first in vivo demonstration that the formation of cerebrosides and sphingomyelin in peripheral nerves in situ can be simultaneously assured via two metabolically and kinetically distinct pathways that employ different fatty acid pools.We recently demonstrated the synthesis of ceramides in peripheral nerves, both in vivo, following the intraneural injection of palmitate into the sciatic nerves of mice, and in vitro by a mouse sciatic nerve microsomal preparation in the presence of either stearoyl-CoA or lignoceroyl-CoA, and sphingosine, but not in the presence of free fatty acid (Boiron-Sargueil et al., 1992), as was previously observed for the central nervous system (Akanuma and Kishimoto, 1979;Morell and Radin, 1970; Singh and Kishimoto, 1979). No information is available concerning the fate of ceramides in peripheral nerves, while in the central nervous system, in vivo (Carter and Kanfer, 1974) and in vitro (Akanuma and Kishimoto, 1979;Morell and Radin, 1969; Singh and Kishimoto, 1979; Ullman and Radin, 1972) studies have led to conflicting conclusions with respect to the participation of ceramides and galactosylsphingosine (psychosine) in the formation of hydroxylated and nonhydroxylated galactocerebrosides. Similarly, sphingomyelin synthesis has been proposed to occur via the transfer of phosphocholine from CDP-choline, or phosphatidylcholine, to ceramide, and by the condensation of sphingosine phosphocholine with fatty acyl-CoA (Kishimoto, 1983;Sweely, 1991;Spence, 1993).In this paper, we have administered a small amount of an exogenous labeled substrate that is rapidly incorporated into the natural lipid metabolic pathways of mouse sciatic nerves, and studied the fate of the resulting labeled products, in order to identify metabolic precursors of the sphingolipids in this system, and hence to clarify the situation with respect to the pathways implicated in their biosynthesis in situ. Under the conditions that we have established for the in vivo study of peripheral nerve lipid metabolism (Heape et al., 1989(Heape et al., , 1990, the very rapid and almost complete utilisation of the small quantity of substrate administered to the nerves gives access to both the short-term and long-term metabolisms of the labeled exogenous substrate and, hence, to the formation of the metabolic...